CY-1503

DB17605InvestigationalSmall molecule

CY-1503 is a pentasaccharide ethyl glycoside consisting of one alpha-D-sialylosyl residue as a sodium salt, two beta-D-galactopyranosyl residues, one 2-acetamido-beta-Dglucopyranosyl unit, and one alpha-L-fucopyranosyl unit. It was investigated in cardiopulmonary... It was investigated in cardiopulmonary bypass during surgical repair of congenital heart lesions.

Mechanism
Curator reviewed
Code names
CY-1503

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with CY-1503, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account